Skip to main content

Table 1 Patient (n – 141) Characteristics and Univariate Analysis for Impact on Local Control

From: Definitive radiotherapy for early (T1-T2) Glottic Squamous cell carcinoma: a 20 year Cleveland clinic experience

Characteristic

# of Patients(range or %)

p value

Mean Age (yrs) at end of radiation

67 (33–94)

0.9055

Gender

 

0.3902

   male

125 (88.7%)

 

   female

16 (11.3%)

 

Race

 

0.1133

   Caucasian

119 (84.4%)

 

   Non-caucasian

22 (15.6%)

 

Median Pack Years

44 (0–135)

0.6769

Smoker

 

0.3530

   Never

12 (8.5%)

 

   Former

92 (65.2%)

 

   Current

32 (22.7%)

0.5568

   Unknown

5 (3.5%)

 

Heavy Alchohol Use

 

0.0630

   Never (Reference)

89 (63.1%)

 

   Former

21 (14.9%)

0.8836

   Current

19 (13.5%)

0.0222

   Unknown

12 (8.5%)

 

Ant Commissure

 

0.0505

   Involved

71 (50.3%)

 

   Non Involved

52 (36.9%)

 

   Unknown

18 (12.8%)

 

Tumor Bulk

 

0.6386

   Bulky

55 ( 39%)

 

   Non bulky

86 ( 61%)

 

Hemoglobin (g/dL)

14.2

 

Grade

 

0.6614

   Well (Reference)

43 (30.5%)

 

   Moderate

57 (40.4%)

0.7192

   Poor

14 (10%)

0.3646

   Unknown

27 (19.1%)

 

Stage (T2b vs T1a/b/2a)

 

0.0205

   1a

65 ( 46%)

0.0033

   1b

21 (14.9%)

0.1766

   2a

29 (20.6%)

0.0621

   2b (Reference)

25 (17.7%)

 

   Unknown

1 (1%)

 

Subglottic Ext

 

0.0505

   Yes

18 (12.8%)

 

   No

96 (68.1%)

 

   Missing

27 (19.2%)

 

Supraglottic Ext

 

0.4668

   Yes

30 (21.2%)

 

   No

87 (61.7%)

 

   Missing

24 (17%)

 

Median Overall Treatment Time (wks)

6.5 (4–9.7)

 

Radiation Dose (cGy) as Continous

6820 (6300–7264)

0.0367

   ≤66 Gy

45

 

   > 66 Gy

96

 

Median Dose/Fraction

212 (176–256)

0.1353

   ≤2Gy/fx

45 (31.9%)

 

   >2Gy/fx

95 (67.4%)

 

missing

1 (1%)

 

Mean Follow-Up (month)

67.7 (0–239)

Â